Literature DB >> 26722549

Clinical features of MELAS and its relation with A3243G gene point mutation.

Jin Zhang1, Junhong Guo1, Wanghui Fang1, Qili Jun1, Kaili Shi2.   

Abstract

Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) mostly occur in children. The point mutation A3243G of mitochondrial DNA (mtDNA) may work as a specific bio-marker for mitochondrial disorders. The related clinical features, however, may vary among individuals. This study therefore investigated the relation between MELAS clinical features and point mutation A3243G of mtDNA, in an attempt to provide further evidences for genetic diagnosis of MELAS. Children with MELAS-like syndromes were tested for both blood lactate level and point mutation A3243G of mtDNA. Further family study was performed by mtDNA mutation screening at the same loci for those who had positive gene mutation at A3243G loci. Those who were negative for A3243G point mutation were examined by muscle biopsy and genetic screening. Both clinical and genetic features were analyzed. In all 40 cases with positive A3243G mutation, 36 children fitted clinical diagnosis of MELAS. In other 484 cases with negative mutation, only 8 children were clinically diagnosed with MELAS. Blood lactate levels in both groups were all elevated (P>0.05). In a further genetic screening of 28 families, 10 biological mothers and 8 siblings of MELAS children had positive A3243G point mutations but without any clinical symptoms. Certain difference existed in the clinical manifestations between children who were positive and negative for A3243G mutation of mtDNA but without statistical significance. MELAS showed maternal inheritance under most circumstances.

Entities:  

Keywords:  MELAS; maternal inheritance; mitochondrial DNA; point mutation

Mesh:

Substances:

Year:  2015        PMID: 26722549      PMCID: PMC4680494     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

Review 1.  Epigenetics, epidemiology and mitochondrial DNA diseases.

Authors:  Patrick F Chinnery; Hannah R Elliott; Gavin Hudson; David C Samuels; Caroline L Relton
Journal:  Int J Epidemiol       Date:  2012-01-28       Impact factor: 7.196

Review 2.  Mitochondrial medicine: to a new era of gene therapy for mitochondrial DNA mutations.

Authors:  Hélène Cwerman-Thibault; José-Alain Sahel; Marisol Corral-Debrinski
Journal:  J Inherit Metab Dis       Date:  2010-06-23       Impact factor: 4.982

3.  The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.

Authors:  Anna Lembke; Rowena Gomez; Lakshika Tenakoon; Jennifer Keller; Gregory Cohen; Gordon H Williams; Fredric B Kraemer; Alan F Schatzberg
Journal:  Psychoneuroendocrinology       Date:  2012-06-21       Impact factor: 4.905

4.  Exogenous gangliosides increase the release of brain-derived neurotrophic factor.

Authors:  Seung T Lim; Kamilla Esfahani; Valeriya Avdoshina; Italo Mocchetti
Journal:  Neuropharmacology       Date:  2010-10-28       Impact factor: 5.250

5.  Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.

Authors:  J Halter; Wmm Schüpbach; A Gratwohl; M Hirano; C Casali; R Elhasid; K Fay; S Hammans; I Illa; L Kappeler; S Krähenbühl; T Lehmann; H Mandel; R Marti; H Mattle; K Orchard; D Savage; C M Sue; D Valcarcel
Journal:  Bone Marrow Transplant       Date:  2010-05-03       Impact factor: 5.483

Review 6.  The mitochondrial proteome and human disease.

Authors:  Sarah E Calvo; Vamsi K Mootha
Journal:  Annu Rev Genomics Hum Genet       Date:  2010       Impact factor: 8.929

Review 7.  Biomarkers for mitochondrial respiratory chain disorders.

Authors:  Anu Suomalainen
Journal:  J Inherit Metab Dis       Date:  2010-10-13       Impact factor: 4.982

Review 8.  A neurological perspective on mitochondrial disease.

Authors:  Robert McFarland; Robert W Taylor; Douglass M Turnbull
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

9.  Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation.

Authors:  Paul de Laat; Saskia Koene; Lambert P W J van den Heuvel; Richard J T Rodenburg; Mirian C H Janssen; Jan A M Smeitink
Journal:  J Inherit Metab Dis       Date:  2012-03-09       Impact factor: 4.982

10.  Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease.

Authors:  Joanne Clark; Sonika Reddy; Kangni Zheng; Rebecca A Betensky; David K Simon
Journal:  BMC Med Genet       Date:  2011-05-19       Impact factor: 2.103

View more
  4 in total

1.  Wernicke-Korsakoff syndrome associated with mtDNA disease.

Authors:  Idris Janos Jimoh; Barbara Sebe; Peter Balicza; Mariann Fedor; Ilona Pataky; Gabor Rudas; Aniko Gal; Gabriella Inczedy-Farkas; Gyorgy Nemeth; Maria Judit Molnar
Journal:  Ther Adv Neurol Disord       Date:  2020-07-30       Impact factor: 6.570

2.  Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.

Authors:  Yi Yang; Han Wu; Xiangjin Kang; Yanhui Liang; Ting Lan; Tianjie Li; Tao Tan; Jiangyun Peng; Quanjun Zhang; Geng An; Yali Liu; Qian Yu; Zhenglai Ma; Ying Lian; Boon Seng Soh; Qingfeng Chen; Ping Liu; Yaoyong Chen; Xiaofang Sun; Rong Li; Xiumei Zhen; Ping Liu; Yang Yu; Xiaoping Li; Yong Fan
Journal:  Protein Cell       Date:  2018-01-09       Impact factor: 14.870

3.  Molecular Dynamics Simulation of T10609C and C10676G Mutations of Mitochondrial ND4L Gene Associated With Proton Translocation in Type 2 Diabetes Mellitus and Cataract Patients.

Authors:  Wanda Destiarani; Rahmaniar Mulyani; Muhammad Yusuf; Iman Permana Maksum
Journal:  Bioinform Biol Insights       Date:  2020-12-16

4.  Data-independent acquisition-based quantitative proteomic analysis of m.3243A>G MELAS reveals novel potential pathogenesis and therapeutic targets.

Authors:  Xueli Chang; Zhaoxu Yin; Wei Zhang; Jiaying Shi; Chuanqiang Pu; Qiang Shi; Juan Wang; Jing Zhang; Li Yan; Wenqu Yang; Junhong Guo
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.